Bionet Corp. Statistics
Bionet Corp. (1784) Stock Statistics & Valuation Metrics
Total Valuation
Bionet Corp. has a market cap or net worth of TWD 2.32B. The enterprise value is TWD 3.45B.
- Market Cap
- TWD 2.32B
- Enterprise Value
- TWD 3.45B
Share Statistics
Bionet Corp. has 53,121,190 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 53,121,190
- Owned by Insiders
- ―
- Owned by Institutions
- 0.09%
Financial Efficiency
Bionet Corp.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -0.02%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- -0.02%
- Return on Capital Employed (ROCE)
- -0.01
- Revenue Per Employee
- 15.46M
- Profits Per Employee
- 642.83K
- Employee Count
- 80
- Asset Turnover
- 0.40
- Inventory Turnover
- 4.39
Valuation Ratios
The current PE Ratio of Bionet Corp. is 41.99. Bionet Corp.’s PEG ratio is -2.11.
- PE Ratio
- 41.99
- PS Ratio
- 1.83
- PB Ratio
- 1.22
- Price to FCF
- 24.61
- Price to Operating Cash Flow
- 7.67
- PEG Ratio
- -2.11
Income Statement
In the last 12 months, Bionet Corp. had revenue of 1.24B and earned 51.43M in profits. Earnings per share was 1.02.
- Revenue
- 1.24B
- Gross Profit
- 683.87M
- Operating Income
- -14.47M
- Pretax Income
- 19.27M
- Net Income
- 51.43M
- EBITDA
- 47.87M
- Earnings Per Share (EPS)
- 1.02
Cash Flow
In the last 12 months, operating cash flow was 195.41M and capital expenditures -99.34M, giving a free cash flow of 96.07M billion.
- Operating Cash Flow
- 195.41M
- Free Cash Flow
- 96.07M
- Free Cash Flow per Share
- 3.04
Dividends & Yields
Bionet Corp. pays an annual dividend of ―, resulting in a dividend yield of 1.92%
- Dividend Per Share
- ―
- Dividend Yield
- 1.92%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.15%
- Earnings Yield
- 3.12%
Stock Price Statistics
- Beta
- 0.81
- 52-Week Price Change
- -53.73%
- 50-Day Moving Average
- 56.77
- 200-Day Moving Average
- 69.39
- Relative Strength Index (RSI)
- 17.52
- Average Volume (3m)
- 73.34K
Important Dates
Bionet Corp. upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- May 08, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Bionet Corp. as a current ratio of 4.62, with Debt / Equity ratio of 9.14%
- Current Ratio
- 4.62
- Quick Ratio
- 4.31
- Debt to Market Cap
- 0.84
- Net Debt to EBITDA
- -2.92
- Interest Coverage Ratio
- -9.64
Taxes
In the past 12 months, Bionet Corp. has paid 18.43M in taxes.
- Income Tax
- 18.43M
- Effective Tax Rate
- 0.96
Enterprise Valuation
Bionet Corp. EV to EBITDA ratio is 35.58, with an EV/FCF ratio of 23.54.
- EV to Sales
- 1.75
- EV to EBITDA
- 35.58
- EV to Free Cash Flow
- 23.54
- EV to Operating Cash Flow
- 11.57
Balance Sheet
Bionet Corp. has TWD 1.46B in cash and marketable securities with TWD 141.63M in debt, giving a net cash position of TWD 1.32B billion.
- Cash & Marketable Securities
- TWD 1.46B
- Total Debt
- TWD 141.63M
- Net Cash
- TWD 1.32B
- Net Cash Per Share
- TWD 24.87
- Tangible Book Value Per Share
- TWD 68.75
Margins
Gross margin is 55.80%, with operating margin of -0.59%, and net profit margin of 3.54%.
- Gross Margin
- 55.80%
- Operating Margin
- -0.59%
- Pretax Margin
- 1.66%
- Net Profit Margin
- 3.54%
- EBITDA Margin
- 4.91%
- EBIT Margin
- 0.32%
Analyst Forecast
The average price target for Bionet Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 5.41%
- EPS Growth Forecast
- -19.02%
